Pulmonary mucosa-associated lymphoma in a patient with von Hippel-Lindau disease.

J Surg Case Rep

Department of Thoracic and GI Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Published: July 2015

A 61-year-old female with a past medical history significant for von Hippel-Lindau (VHL) syndrome presented with multiple bilateral pulmonary lesions found on surveillance computed tomography scan. Positron emission tomography demonstrated avidity in a lesion in the right upper lobe. After an equivocal biopsy, a lobectomy via a thoracoscopic approach was performed as this lesion was concerning for a primary lung cancer. Pathology revealed a diagnosis of pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma. To our knowledge, this is the first reported case of a pulmonary MALT lymphoma in a patient with VHL.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500894PMC
http://dx.doi.org/10.1093/jscr/rjv080DOI Listing

Publication Analysis

Top Keywords

pulmonary mucosa-associated
8
lymphoma patient
8
von hippel-lindau
8
malt lymphoma
8
pulmonary
4
mucosa-associated lymphoma
4
patient von
4
hippel-lindau disease
4
disease 61-year-old
4
61-year-old female
4

Similar Publications

Introduction: There is little information in the literature on the early, sub-clinical stage and laboratory test results in patients with primary mucosa-associated lymphoid tissue (MALT) lymphoma of the lung, a rare disease.

Case Description: In a 75-year-old man, an open lung biopsy-confirmed diagnosis of primary pulmonary lymphoma was preceded by almost six months of anaemia of inflammatory disease and monocytosis without any pulmonary symptoms. When he developed a dry cough, increasing dyspnoea and marked weight loss, these changes deepened and became associated with reactive thrombocytosis; markedly increased ferritin and C-reactive protein (positive acute-phase reactants), as well as reduced albumin and transferrin (negative acute-phase reactants).

View Article and Find Full Text PDF

Although rearrangement of the MYC oncogene (MYC-R) is frequently observed in aggressive B-cell lymphomas, it is extremely rare in T-cell malignancies. A 64-year-old man who had been under observation for several years because of asymptomatic pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALToma) was admitted to our hospital because of poor general condition and hypotension. Blood tests revealed thrombocytopenia and elevated serum lactate dehydrogenase levels, whereas computed tomography revealed systemic lymphadenopathy and splenomegaly.

View Article and Find Full Text PDF

Rare Pulmonary MALT Lymphomas and Its Differential Diagnosis On Chest CT.

J Investig Med High Impact Case Rep

December 2024

Department of Respiratory Medicine, Weifang People's Hospital, The First Affiliated Hospital of Weifang Medical College, Weifang, China.

Pulmonary nodules caused by mucosa-associated lymphomas (MALT lymphomas) are uncommon, comprising for less than 0.5% of all primary lung tumors. While biopsy is the main method for diagnosing the disease, the significance of differential pulmonary diagnosis based on imaging is often overlooked.

View Article and Find Full Text PDF
Article Synopsis
  • - Mucosa-associated lymphoid tissue (MALT) lymphoma is a rare B-cell lymphoma that can affect various organs, and patients with Sjögren's syndrome (SjS) have significantly higher risks of developing it.
  • - A case study is presented of primary thymic MALT lymphoma found incidentally during routine chest imaging, alongside cystic lung disease, primarily observed in women with SjS.
  • - Imaging techniques revealed a large mass in the mediastinum and numerous pulmonary cysts; the diagnosis was confirmed via biopsy, and treatment improved lung function, emphasizing the link between SjS and MALT lymphoma's lung manifestations.
View Article and Find Full Text PDF

Sjögren's Disease and Gastroesophageal Reflux Disease: What Is Their Evidence-Based Link?

Medicina (Kaunas)

November 2024

Department of Personalised Medicine, State Research Institute Center for Innovative Medicine, Santariskiu st. 5, LT-08405 Vilnius, Lithuania.

Sjögren's disease (SjD), or primary Sjögren's syndrome (pSS), is a heterogeneous chronic autoimmune disorder with multiple clinical manifestations that can develop into non-Hodgkin's lymphoma in mucosa-associated lymphoid tissue. SjD is one of the autoimmune diseases with the maximum delayed diagnosis due to its insidious onset, heterogeneous clinical features and varied course. It is increasingly recognized that extraglandular manifestations represent a clinical challenge for patients with SjD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!